Thought Leader Select Names Scott to Lead Research Teams

April 22, 2010 (CHAPEL HILL, NC)—Thought Leader Select, a North Carolina company dedicated to better engagement and more sophisticated deployment of key opinion leaders (KOLs) for the pharmaceutical and biotechnology industries, announces the hiring of Lynda Scott as research manager.

Ms. Scott, a native of Johannesburg, South Africa, has served as a research associate at the firm for the last three years.  In addition to her work at Thought Leader Select, Scott brings nearly a decade of valuable clinical experience to the firm, spending seven years as a nuclear medicine radiographer at the Flora Clinic and Milpark Hospital, as well as the Rosebank Clinic, all in Johannesburg.  At the Rosebank Clinic, Scott managed all aspects of the nuclear medicine practice, including patient management, general practice management, record-keeping, and adherence to industry protocols and regulations.

Scott earned a Master of Health Science degree from the University of Sydney, Austrailia, in 2004, graduating with highest honors. During her time as a student at the University of Sydney, Scott twice presented her work in imaging at Duke University Medical Center, and in 2004, the Journal of Nuclear Medicine Technology published her work covering the role of MIBG imaging in early diagnosis of cardiac autonomic neuropathy in diabetes patients.

Since completing her master’s degree, Scott has worked as an independent medical writer, contributing to two HIV-related manuscripts for GlaxoSmithKline for medical journal publication.  Scott has served as an admissions representative for the United States Military Academy at West Point since 2006, and she also spent five years as a counselor for the Boy Scouts of America, mentoring Eagle Scouts in achieving personal fitness merit badges.

“We are proud to have Lynda as a member of our team of researchers at Thought Leader Select, and, based on her previous work for us, we have very high expectations of her as a research manager, “ said Dr. Clarissa Noureddine, senior research manager at the firm. “I’m excited to have a colleague of Lynda’s stature in the medical community to collaborate with me in leading our breakthrough work in KOL identification for pharma companies.  She brings a deep background of clinical experience to her work, coupled with a disciplined approach to giving our clients the best research data possible.”

About Thought Leader Select

Thought Leader Select is a specialty firm focused on providing solutions—research, technology tools and focused advice/consulting—for more effective KOL engagement and deployment in the healthcare industry. Thought Leader Select’s groundbreaking work bridges the areas of research, communications and technology. With more than 70 years of combined experience working in and with the pharmaceutical industry, Thought Leader Select is addressing needs for better engagement and more sophisticated deployment of KOLs during drug development and the life cycle of the brand.

Media Contact:

Kristen Smithwick

Vice President of Marketing & Planning

252-945-8352

ksmithwick@thoughtleaderselect.com

More Posts

Mapping the Patient Journey

By Paul Meade, Patient Engagement Lead  Mapping the Patient Journey A vital step to improving patient engagement is defining and understanding the patient journey. While

Share:

Send Us A Message